Experienced in Folate-Deficiency Anemia

Dr. Michael M. Tuchman

Neurology
Michael M Tuchman MD PA
3355 Burns Rd, Suite 201, 
Palm Beach Gardens, FL 
Offers Telehealth
Experienced in Folate-Deficiency Anemia
Michael M Tuchman MD PA
3355 Burns Rd, Suite 201, 
Palm Beach Gardens, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Tuchman is a Neurologist in Palm Beach Gardens, Florida. Dr. Tuchman is rated as an Experienced provider by MediFind in the treatment of Folate-Deficiency Anemia. His top areas of expertise are Susac Syndrome, Neuralgia, Cerebellar Degeneration, and Peripheral Neuropathy.

His clinical research consists of co-authoring 9 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Florida College Of Medicine
Specialties
Neurology
Licenses
Psychiatry & Neurology in FL
Hospital Affiliations
Jupiter Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

MICHAEL M TUCHMAN MD PA
3355 Burns Rd, Suite 201, Palm Beach Gardens, FL 33410

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Donanemab Follow-On Study: Safety, Tolerability, And Efficacy in Symptomatic Alzheimer's Disease With Validation of Remote Neuropsychological Assessments
Donanemab Follow-On Study: Safety, Tolerability, And Efficacy in Symptomatic Alzheimer's Disease With Validation of Remote Neuropsychological Assessments
Enrollment Status: Completed
Publish Date: June 13, 2025
Intervention Type: Drug, Other
Study Drug: Donanemab
Study Phase: Phase 2
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Drug
Study Drug: ALZ-801
Study Phase: Phase 3
A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease
A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease
Enrollment Status: Completed
Publish Date: February 18, 2025
Intervention Type: Drug
Study Drug: BPN14770
Study Phase: Phase 2
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
Enrollment Status: Completed
Publish Date: June 28, 2024
Intervention Type: Drug
Study Drugs: Galcanezumab, Rimegepant
Study Phase: Phase 4
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability and Efficacy of LY3002813 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: October 13, 2022
Intervention Type: Drug
Study Drug: LY3002813
Study Phase: Phase 2
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: September 02, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

9 Total Publications

Perspectives on the impact of painful diabetic peripheral neuropathy in a multicultural population.
Perspectives on the impact of painful diabetic peripheral neuropathy in a multicultural population.
Journal: Clinical diabetes and endocrinology
Published: August 23, 2017
Similar Doctors
Experienced in Folate-Deficiency Anemia
Dr. Noor Yono
Neurology | Psychiatry
Experienced in Folate-Deficiency Anemia
Dr. Noor Yono
Neurology | Psychiatry

Premier Neurology And Wellness Center LLC

1050 Se Monterey Rd, Suite 201, 
Stuart, FL 
 (25.6 miles away)
772-210-2447
Languages Spoken:
English, Arabic, Armenian, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Noor Yono is a Neurologist and a Psychiatrist in Stuart, Florida. Dr. Yono is rated as an Advanced provider by MediFind in the treatment of Folate-Deficiency Anemia. Her top areas of expertise are Landau-Kleffner Syndrome, Memory Loss, Migraine, and Chronic Demyelinizing Neuropathy with IgM Monoclonal. Dr. Yono is currently accepting new patients.

Experienced in Folate-Deficiency Anemia
Dr. Henry Calas
Neurology
Experienced in Folate-Deficiency Anemia
Dr. Henry Calas
Neurology
827 Se 5th St, 
Stuart, FL 
 (27.0 miles away)
772-223-5525
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Henry Calas is a Neurologist in Stuart, Florida. Dr. Calas is rated as an Advanced provider by MediFind in the treatment of Folate-Deficiency Anemia. His top areas of expertise are Methylmalonic Acidemia with Homocystinuria, Homocystinuria, Methylmalonic Acidemia, and Inborn Amino Acid Metabolism Disorder. Dr. Calas is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tuchman's expertise for a condition
ConditionClose
      View All 25 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile